| Avon C Coffman, DO | |
|
5330 N Oak Trfy, Ste 201, Kansas City, MO 64118-4699 | |
| (816) 454-0666 | |
| (816) 454-1694 |
| Full Name | Avon C Coffman |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 5330 N Oak Trfy, Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760458301 | NPI | - | NPPES |
| P00331181 | Other | KS | RAILROAD MEDICARE |
| 040008580 | Other | MO | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | R7G78 (Missouri) | Primary |
| Entity Name | Midwest Division - Lrhc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639362460 PECOS PAC ID: 0941119150 Enrollment ID: O20031105000738 |
News Archive
PDL BioPharma, Inc. today announced that on December 15, 2010, the U.S. Patent and Trademark Office (the PTO) terminated its interference proceeding between certain claims of the Company's Queen et al., U.S. Patent No. 5,585,089, (the '089 Patent) and certain pending claims of Adair et al., U.S. Application No. 08/846,658, (the '658 Application) in favor of the Company's '089 Patent.
In a recent paper published in the prestigious journal Cell, researchers from Sweden and Italy show that inflammatory response in Multisystem Inflammatory Syndrome in Children associated with coronavirus disease (COVID-19) differs from the cytokine storm found in severe acute illness, involving autoantibodies at the same time and sharing several features with Kawasaki disease.
The heart of the Patient Protection and Affordable Care Act is the requirement that every American purchase health insurance or pay a penalty. Justice Anthony Kennedy-;widely considered the "swing vote" on cases that divide the Supreme Court evenly along ideological lines-;raised concerns on Tuesday that this individual mandate "changes the relationship of the federal government to the individual in the very fundamental way."
In locker rooms from your local high school to the National Football League, concern about the spread of potentially deadly bacteria and infections are leading training staffs to take extreme measures to prevent outbreaks. Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, could be close to offering a solution to the problem.
› Verified 5 days ago
| Entity Name | Cameron Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811905375 PECOS PAC ID: 5092622001 Enrollment ID: O20040113000619 |
News Archive
PDL BioPharma, Inc. today announced that on December 15, 2010, the U.S. Patent and Trademark Office (the PTO) terminated its interference proceeding between certain claims of the Company's Queen et al., U.S. Patent No. 5,585,089, (the '089 Patent) and certain pending claims of Adair et al., U.S. Application No. 08/846,658, (the '658 Application) in favor of the Company's '089 Patent.
In a recent paper published in the prestigious journal Cell, researchers from Sweden and Italy show that inflammatory response in Multisystem Inflammatory Syndrome in Children associated with coronavirus disease (COVID-19) differs from the cytokine storm found in severe acute illness, involving autoantibodies at the same time and sharing several features with Kawasaki disease.
The heart of the Patient Protection and Affordable Care Act is the requirement that every American purchase health insurance or pay a penalty. Justice Anthony Kennedy-;widely considered the "swing vote" on cases that divide the Supreme Court evenly along ideological lines-;raised concerns on Tuesday that this individual mandate "changes the relationship of the federal government to the individual in the very fundamental way."
In locker rooms from your local high school to the National Football League, concern about the spread of potentially deadly bacteria and infections are leading training staffs to take extreme measures to prevent outbreaks. Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, could be close to offering a solution to the problem.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Avon C Coffman, DO 5330 N Oak Trfy, Ste 201, Kansas City, MO 64118-4699 Ph: (816) 454-0666 | Avon C Coffman, DO 5330 N Oak Trfy, Ste 201, Kansas City, MO 64118-4699 Ph: (816) 454-0666 |
News Archive
PDL BioPharma, Inc. today announced that on December 15, 2010, the U.S. Patent and Trademark Office (the PTO) terminated its interference proceeding between certain claims of the Company's Queen et al., U.S. Patent No. 5,585,089, (the '089 Patent) and certain pending claims of Adair et al., U.S. Application No. 08/846,658, (the '658 Application) in favor of the Company's '089 Patent.
In a recent paper published in the prestigious journal Cell, researchers from Sweden and Italy show that inflammatory response in Multisystem Inflammatory Syndrome in Children associated with coronavirus disease (COVID-19) differs from the cytokine storm found in severe acute illness, involving autoantibodies at the same time and sharing several features with Kawasaki disease.
The heart of the Patient Protection and Affordable Care Act is the requirement that every American purchase health insurance or pay a penalty. Justice Anthony Kennedy-;widely considered the "swing vote" on cases that divide the Supreme Court evenly along ideological lines-;raised concerns on Tuesday that this individual mandate "changes the relationship of the federal government to the individual in the very fundamental way."
In locker rooms from your local high school to the National Football League, concern about the spread of potentially deadly bacteria and infections are leading training staffs to take extreme measures to prevent outbreaks. Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, could be close to offering a solution to the problem.
› Verified 5 days ago
Dr. Kim Ann Suk Baker, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3042 | |
Dr. Bart C Patenaude, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 E 54th St, Kansas City, MO 64110 Phone: 816-519-3013 | |
Dr. Ann Bailey Robinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr, Suite 450, Kansas City, MO 64114 Phone: 816-942-7200 Fax: 816-941-2767 | |
Dr. Pamela Nicklaus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Robert Weatherly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Joseph R Guastello, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Ste 512, Kansas City, MO 64111 Phone: 816-932-8663 | |
Dr. Thomas Cotton, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |